BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-warhi T, Sabt A, Elkaeed EB, Eldehna WM. Recent advancements of coumarin-based anticancer agents: An up-to-date review. Bioorganic Chemistry 2020;103:104163. [DOI: 10.1016/j.bioorg.2020.104163] [Cited by in Crossref: 24] [Cited by in F6Publishing: 50] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Abo-Ashour MF, Almahli H, Bonardia A, Khalil A, Al-Warhi T, Al-Rashood ST, Abdel-Aziz HA, Nocentini A, Supuran CT, Eldehna WM. Enaminone-based carboxylic acids as novel non-classical carbonic anhydrases inhibitors: design, synthesis and in vitro biological assessment. J Enzyme Inhib Med Chem 2022;37:2256-64. [PMID: 36000171 DOI: 10.1080/14756366.2022.2114079] [Reference Citation Analysis]
2 Xu J, Yan C, Wu Z, Xu M, Wei T, He T, Zhou W, Zhang Y, Zhang J, Yang B. Synergistic reduction and oxidation system using 4,7-dihydroxycoumarin as a green photocatalyst for efficient nitrobenzene degradation. Separation and Purification Technology 2022;301:121849. [DOI: 10.1016/j.seppur.2022.121849] [Reference Citation Analysis]
3 Halit S, Benazzouz-touami A, Makhloufi-chebli M, Bouaziz ST, Ighilahriz K, Robert A, Machado-rodrigues C. Design, Synthesis, Biological evaluation of Isonicotinoyl-pyrazolyl-coumarin derivatives and computational study. Journal of Molecular Structure 2022;1265:133487. [DOI: 10.1016/j.molstruc.2022.133487] [Reference Citation Analysis]
4 Ibrahim HS, Abdelrahman MA, Nocentini A, Bua S, Abdel-aziz HA, Supuran CT, Abou-seri SM, Eldehna WM. Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity. Bioorganic Chemistry 2022;126:105888. [DOI: 10.1016/j.bioorg.2022.105888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bourzikat O, El Abbouchi A, Ghammaz H, El Brahmi N, El Fahime E, Paris A, Daniellou R, Suzenet F, Guillaumet G, El Kazzouli S. Synthesis, Anticancer Activities and Molecular Docking Studies of a Novel Class of 2-Phenyl-5,6,7,8-tetrahydroimidazo [1,2-b]pyridazine Derivatives Bearing Sulfonamides. Molecules 2022;27:5238. [DOI: 10.3390/molecules27165238] [Reference Citation Analysis]
6 N MK, Nukala SK, Thirukovela NS, Sreerama R, E RS, Kamarajugadda P, Narsimha S. Ramachary-Bressy-Wang [3+2]cycloaddition reaction: Synthesis of fully decorated 1,2,3-triazoles as potent anticancer and EGFR inhibitors. Journal of Molecular Structure 2022;1262:132975. [DOI: 10.1016/j.molstruc.2022.132975] [Reference Citation Analysis]
7 Katariya KD, Soni R, Nakum KJ, Soman SS, Hagaar M. Coumarin derivatives containing schiff base and ester mesogenic core: Synthesis, mesomorphic behaviour and DFT calculations. Journal of Molecular Structure 2022;1262:133043. [DOI: 10.1016/j.molstruc.2022.133043] [Reference Citation Analysis]
8 Zarenezhad E, Montazer MN, Tabatabaee M, Irajie C, Iraji A. New solid phase methodology for the synthesis of biscoumarin derivatives: experimental and in silico approaches. BMC Chem 2022;16:53. [PMID: 35820918 DOI: 10.1186/s13065-022-00844-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chung G, Kim SK. Therapeutics for Chemotherapy-Induced Peripheral Neuropathy: Approaches with Natural Compounds from Traditional Eastern Medicine. Pharmaceutics 2022;14:1407. [DOI: 10.3390/pharmaceutics14071407] [Reference Citation Analysis]
10 Kumar S, Saroha B, Kumar G, Lathwal E, Kumar S, Parshad B, Kumari M, Kumar N, Mphahlele-makgwane MM, Makgwane PR. Recent Developments in Nanocatalyzed Green Synthetic Protocols of Biologically Potent Diverse O-Heterocycles—A Review. Catalysts 2022;12:657. [DOI: 10.3390/catal12060657] [Reference Citation Analysis]
11 Jana A, Ali D, Bhaumick P, Choudhury LH. Sc(OTf)3-Mediated One-Pot Synthesis of Coumarin-Fused Furans: A Thiol-Dependent Reaction for the Easy Access of 2-Phenyl-4H-furo[3,2-c]chromen-4-ones. J Org Chem 2022. [PMID: 35642787 DOI: 10.1021/acs.joc.2c00353] [Reference Citation Analysis]
12 Tawfik HO, Shaldam MA, Nocentini A, Salem R, Almahli H, Al-Rashood ST, Supuran CT, Eldehna WM. Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity. J Enzyme Inhib Med Chem 2022;37:1043-52. [PMID: 35437108 DOI: 10.1080/14756366.2022.2056734] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Keri RS, Budagumpi S, Balappa Somappa S. Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure-activity relationship. J Clin Pharm Ther 2022. [PMID: 35288962 DOI: 10.1111/jcpt.13644] [Reference Citation Analysis]
14 Khatua S, Taraphder S. In the footsteps of an inhibitor unbinding from the active site of human carbonic anhydrase II. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2048075] [Reference Citation Analysis]
15 Salama EE, Althobaiti IO, Haukka M, Boraei ATA. Synthesis, X-ray Single-Crystal Analysis, and Anticancer Activity Evaluation of New Alkylsulfanyl-Pyridazino[4,5-b]indole Compounds as Multitarget Inhibitors of EGFR and Its Downstream PI3K-AKT Pathway. Crystals 2022;12:353. [DOI: 10.3390/cryst12030353] [Reference Citation Analysis]
16 Rullo M, Cipolloni M, Catto M, Colliva C, Miniero DV, Latronico T, de Candia M, Benicchi T, Linusson A, Giacchè N, Altomare CD, Pisani L. Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies. J Med Chem 2022. [PMID: 35195417 DOI: 10.1021/acs.jmedchem.1c01784] [Reference Citation Analysis]
17 Wu M, Su X, Wu Y, Luo Y, Guo Y, Xue Y. Glycosylated coumarins, flavonoids, lignans and phenylpropanoids from Wikstroemia nutans and their biological activities. Beilstein J Org Chem 2022;18:200-7. [DOI: 10.3762/bjoc.18.23] [Reference Citation Analysis]
18 Boudreau A, Richard AJ, Harvey I, Stephens JM. Artemisia scoparia and Metabolic Health: Untapped Potential of an Ancient Remedy for Modern Use. Front Endocrinol 2022;12:727061. [DOI: 10.3389/fendo.2021.727061] [Reference Citation Analysis]
19 Eldehna WM, Taghour MS, Al-Warhi T, Nocentini A, Elbadawi MM, Mahdy HA, Abdelrahman MA, Alotaibi OJ, Aljaeed N, Elimam DM, Afarinkia K, Abdel-Aziz HA, Supuran CT. Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms. J Enzyme Inhib Med Chem 2022;37:531-41. [PMID: 34991416 DOI: 10.1080/14756366.2021.2024528] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
20 G AC, Gondru R, Li Y, Banothu J. Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry. Eur J Med Chem 2022;227:113921. [PMID: 34715585 DOI: 10.1016/j.ejmech.2021.113921] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
21 Abdel Ghany LMA, El-dydamony NM, Helwa AA, Abdelraouf SM, Abdelnaby RM. Coumarin-acetohydrazide derivatives as novel antiproliferative agents via VEGFR-2/AKT axis inhibition and apoptosis triggering. New J Chem . [DOI: 10.1039/d2nj02436e] [Reference Citation Analysis]
22 Harismah K, Da’i M, Azimzadeh-sadeghi S, Poursafa P, Mirzaei M, Salarrezaei E. Interactions of coumarin derivatives with monoamine oxidase biomarkers: In silico approach. MGC 2021. [DOI: 10.3233/mgc-210162] [Reference Citation Analysis]
23 Balewski Ł, Szulta S, Jalińska A, Kornicka A. A Mini-Review: Recent Advances in Coumarin-Metal Complexes With Biological Properties. Front Chem 2021;9:781779. [PMID: 34926402 DOI: 10.3389/fchem.2021.781779] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
24 Wan Y, Fang G, Chen H, Deng X, Tang Z. Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation. Eur J Med Chem 2021;226:113837. [PMID: 34530384 DOI: 10.1016/j.ejmech.2021.113837] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
25 Elkaeed EB, Salam HAAE, Sabt A, Al-Ansary GH, Eldehna WM. Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules. Molecules 2021;26:7611. [PMID: 34946704 DOI: 10.3390/molecules26247611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Fuentes-Aguilar A, Merino-Montiel P, Montiel-Smith S, Meza-Reyes S, Vega-Báez JL, Puerta A, Fernandes MX, Padrón JM, Petreni A, Nocentini A, Supuran CT, López Ó, Fernández-Bolaños JG. 2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases. J Enzyme Inhib Med Chem 2022;37:168-77. [PMID: 34894971 DOI: 10.1080/14756366.2021.1998026] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
27 Lu G, Dong J, Fan C, Tu Y, Pu S. A coumarin-based fluorescent probe for specific detection of cysteine in the lysosome of living cells. Bioorg Chem 2021;119:105558. [PMID: 34922090 DOI: 10.1016/j.bioorg.2021.105558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
28 Khomenko TM, Shtro AA, Galochkina AV, Nikolaeva YV, Petukhova GD, Borisevich SS, Korchagina DV, Volcho KP, Salakhutdinov NF. Monoterpene-Containing Substituted Coumarins as Inhibitors of Respiratory Syncytial Virus (RSV) Replication. Molecules 2021;26:7493. [PMID: 34946573 DOI: 10.3390/molecules26247493] [Reference Citation Analysis]
29 Ortega-Forte E, Rovira A, Gandioso A, Bonelli J, Bosch M, Ruiz J, Marchán V. COUPY Coumarins as Novel Mitochondria-Targeted Photodynamic Therapy Anticancer Agents. J Med Chem 2021;64:17209-20. [PMID: 34797672 DOI: 10.1021/acs.jmedchem.1c01254] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Maračić S, Grbčić P, Shammugam S, Radić Stojković M, Pavelić K, Sedić M, Kraljević Pavelić S, Raić-Malić S. Amidine- and Amidoxime-Substituted Heterocycles: Synthesis, Antiproliferative Evaluations and DNA Binding. Molecules 2021;26:7060. [PMID: 34834151 DOI: 10.3390/molecules26227060] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Wang G, Sun S, Guo H. Current status of carbazole hybrids as anticancer agents. Eur J Med Chem 2021;:113999. [PMID: 34838335 DOI: 10.1016/j.ejmech.2021.113999] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
32 Sharifi-Rad J, Cruz-Martins N, López-Jornet P, Lopez EP, Harun N, Yeskaliyeva B, Beyatli A, Sytar O, Shaheen S, Sharopov F, Taheri Y, Docea AO, Calina D, Cho WC. Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms. Oxid Med Cell Longev 2021;2021:6492346. [PMID: 34531939 DOI: 10.1155/2021/6492346] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
33 Yao H, Li X, Pan X, Xu J, Zhao S, Su Z, Qiu S. Fraxetin exerts anticancer effect in glioma by suppressing MiR-21-3p. Drug Dev Res 2021. [PMID: 34523750 DOI: 10.1002/ddr.21881] [Reference Citation Analysis]
34 Becerra D, Portilla J, Castillo J. 2-Oxo-2H-chromen-7-yl 4-chlorobenzoate. Molbank 2021;2021:M1279. [DOI: 10.3390/m1279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Toan VN, Thanh ND. Synthesis and antiproliferative activity of hybrid thiosemicarbazone derivatives bearing coumarin and d-galactose moieties with EGFR inhibitory activity and molecular docking study. Med Chem Res 2021;30:1868-85. [DOI: 10.1007/s00044-021-02773-y] [Reference Citation Analysis]
36 Simic M, Petkovic M, Jovanovic P, Jovanovic M, Tasic G, Besu I, Zizak Z, Aleksic I, Nikodinovic-Runic J, Savic V. Fragment-type 4-azolylcoumarin derivatives with anticancer properties. Arch Pharm (Weinheim) 2021;:e2100238. [PMID: 34374111 DOI: 10.1002/ardp.202100238] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Sun M, Sun M, Zhang J. Osthole: an overview of its sources, biological activities, and modification development. Med Chem Res 2021;:1-28. [PMID: 34376964 DOI: 10.1007/s00044-021-02775-w] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
38 Gao L, Wang F, Chen Y, Li F, Han B, Liu D. The antithrombotic activity of natural and synthetic coumarins. Fitoterapia 2021;154:104947. [PMID: 34352355 DOI: 10.1016/j.fitote.2021.104947] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Ye L, Yao Q, Xu F, He L, Ding J, Xiao R, Ding L, Luo B. Preparation and antitumor activity of triphenylphosphine-based mitochondrial targeting polylactic acid nanoparticles loaded with 7-hydroxyl coumarin. J Biomater Appl 2021;:8853282211037030. [PMID: 34338057 DOI: 10.1177/08853282211037030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Xu X, Yan Y, Huang W, Mo T, Wang X, Wang J, Li J, Shi S, Liu X, Tu P. Molecular cloning and biochemical characterization of a new coumarin glycosyltransferase CtUGT1 from Cistanche tubulosa. Fitoterapia 2021;153:104995. [PMID: 34293438 DOI: 10.1016/j.fitote.2021.104995] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Bakare SB. Synthesis and anticancer evaluation of some coumarin and azacoumarin derivatives. Polish Journal of Chemical Technology 2021;23:27-34. [DOI: 10.2478/pjct-2021-0013] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Liang T, Sun X, Li W, Hou G, Gao F. 1,2,3-Triazole-Containing Compounds as Anti-Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure-Activity Relationship. Front Pharmacol 2021;12:661173. [PMID: 34177578 DOI: 10.3389/fphar.2021.661173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
43 Wu Y, Chen J, Liao H, Shu X, Duan L, Yang X, He W. Electrochemical transient iodination and coupling for selenylated 4-anilinocoumarin synthesis. Green Synthesis and Catalysis 2021;2:233-6. [DOI: 10.1016/j.gresc.2021.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
44 El-Metwally SA, Abou-El-Regal MM, Eissa IH, Mehany ABM, Mahdy HA, Elkady H, Elwan A, Elkaeed EB. Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents. Bioorg Chem 2021;112:104947. [PMID: 33964580 DOI: 10.1016/j.bioorg.2021.104947] [Cited by in Crossref: 3] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
45 Moya-Alvarado G, Yañez O, Morales N, González-González A, Areche C, Núñez MT, Fierro A, García-Beltrán O. Coumarin-Chalcone Hybrids as Inhibitors of MAO-B: Biological Activity and In Silico Studies. Molecules 2021;26:2430. [PMID: 33921982 DOI: 10.3390/molecules26092430] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
46 Nallajennugari V, Pajaniradje S, Subramanian S, Bhat SA, D P, Bhaskaran S, M SAP, Rajagopalan R. A novel anticancer chromeno-pyrimidine analogue inhibits epithelial-mesenchymal transition in lung adenocarcinoma cells. Toxicol Mech Methods 2021;31:401-12. [PMID: 33736563 DOI: 10.1080/15376516.2021.1902030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ngoc Toan V, Dinh Thanh N, Minh Tri N. 1,3,4-Thiadiazoline−coumarin hybrid compounds containing D-glucose/D-galactose moieties: Synthesis and evaluation of their antiproliferative activity. Arabian Journal of Chemistry 2021;14:103053. [DOI: 10.1016/j.arabjc.2021.103053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Konkoľová E, Hudáčová M, Hamuľaková S, Jendželovský R, Vargová J, Ševc J, Fedoročko P, Kožurková M. Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines. Molecules 2021;26:1133. [PMID: 33672694 DOI: 10.3390/molecules26041133] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
49 Carneiro A, Matos MJ, Uriarte E, Santana L. Trending Topics on Coumarin and Its Derivatives in 2020. Molecules 2021;26:501. [PMID: 33477785 DOI: 10.3390/molecules26020501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
50 Tan L, Liang D, Cheng Y, Xiao W, Chen J. Visible-light-induced tandem radical addition/cyclization of 2-alkenylphenols and CBr 4 for the synthesis of 4-arylcoumarins. Org Chem Front 2021;8:5052-7. [DOI: 10.1039/d1qo00831e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]